Interpretation of the Position Paper on Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-related Cardiovascular Diseases by the Italian Society of Arterial Hypertension (SIIA) in 2023

• Published in: Zhongguo quanke yixue Vol. 27; no. 26; pp. 3197 - 3203
• Main Author: YANG Rong, YANG Ziyu, LIAO Xiaoyang, LIU Lidi, ZHANG Peng, TIAN Chenyu, YANG Hanfei, YAO Yi, JIA Yu, CHENG Yonglang, SHEN Can, JIANG Lihua, DAI Hua
• Format: Journal Article
• Language: Chinese
• Published: Chinese General Practice Publishing House Co., Ltd 01.09.2024
• Subjects: hypertension|remote healthcare|digital medicine|italian society of arterial hypertension|interpretation
• ISSN: 1007-9572
• DOI: 10.12114/j.issn.1007-9572.2024.0096

High prevalence and low control rate of hypertension have brought a significant disease burden globally. In order to improve the level of hypertension prevention and treatment, remote healthcare and digital medicine have been rapidly developed and widely used worldwide. Currently, there are no relevant regulations in China for these technologies. In 2023, the Italian Society of Arterial Hypertension issued a position statement to guide the development, validation, and clinical use of remote medicine and digital healthcare. This article will interpret this position paper, focusing on the forms of application of telemedicine and digital healthcare in managing hypertension and its related cardiovascular diseases, key research evidence, existing advantages, as well as current opportunities and challenges. The aim is to guide general practitioners in China on how to utilize these technologies in managing hypertension and related cardiovascular conditions.